Major neurological events following foam sclerotherapy. | Canada Hyperbarics Skip to main content
Clinical Study Phlebology 2008

Major neurological events following foam sclerotherapy.

Bush RG, Derrick M, Manjoney D — Phlebology, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported two cases of severe neurological complications following foam sclerotherapy.

What They Found

They found two cases of severe neurological alterations, specifically transient ischaemic attack (TIA) and cerebrovascular accident (CVA), after foam sclerotherapy. In both instances, unknown atrial communications led to foam emboli, with one case resolving spontaneously and the other requiring hyperbaric oxygen therapy.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A major limitation of this report is its reliance on only two case descriptions, which limits the generalizability of the findings.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Neurological
Source Pubmed
PubMed ID 18663119
Year Published 2008
Journal Phlebology
MeSH Terms Adult; Aged; Cerebral Angiography; Embolism, Air; Female; Heart Septal Defects, Atrial; Humans; Hyperbaric Oxygenation; Ischemic Attack, Transient; Remission, Spontaneous; Sclerosing Solutions; Sclerotherapy; Stroke; Telangiectasis; Tomography, X-Ray Computed

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology